Member Info for bignose58

Dr Mike is still not a director, although Regent stated he would eventually become one all those years ago. I'm sure they have told him "we will listen to what you have to say"....only to say to him after the take over...."Talk to the hand, cos we're not listening"....LOL

"By becoming part of Regent Pacific, we are planning to help it transform into the first public company to become the engine for the emerging longevity ecosystem and help everyone on the planet live longer and better regardless of their nationality, race, gender, or social status. As part of Regent Pacific, we aim to service the longevity biotechnology industry as well as the health and life insurance industries and become the ultimate instrument to hedge the longevity risk,"said Alex Zhavoronkov, PhD, the founder and CEO of DLI.

Does he really understand what he has led himself and the company into. Will he become Scientific Officer for Longevity, life wise rather than ejaculation wise...LOL or will there be confrontation between him Jim n Jamie. Interesting to see who wags who's tail.

Just copied this link the FFWD BB.

https://www.prnewswire.com/news-releases/regent-pacific-enters-longevity-medicine-business-driven-by-leading-ai-technology-through-acquisition-of-deep-longevity-inc-301123205.html

Its a term Jamie has used a few times.......

Ref to Fortacine which is often used.
A single aligned management team, with deep knowledge of the industry and product (should be "shallow" or even "dried up puddle")

Didn't he also refer to "Deep Dive" or something similar to do with Recordati......if my memory serves me right.....?

We are so lucky they didn't decide to buy Yooya a few months ago as Yooya would have ended up owning us.......LOL

Since it was reasonable to state the Diabolical Boot Company, maybe we should be prepared for the Drowned Longevity Company.....LOL

Its the same with this deal. "Regent Pacific enters longevity medicine business driven by leading AI technology through acquisition of Deep Longevity, Inc" No such acquisition has been made without shareholder approval, so yet again, a false and deliberately investor misleading statement.

Certainly sticking two fingers up to all shareholders.

The.Italian,

Not just misleading given its for 2019, but fraudulent too. "Regent Pacific enters exploding CBD market in Asia through proposed acquisition of Yooya". How can a company enter an exploding market purely from a proposed acquisition, let alone a failed one ???

Heimdal,

Not so immaterial to all the long-term holders that bought in years ago, It certainly is a huge "IF" given their current track record.

If the AI is so good, how did they manage to get it for less than 4mill since there must be far larger companies out there willing to pay a lot more ? They couldn't even keep the offer a secret given the near 100% rise over the last 6 weeks (or was it planned this way to allow certain people to buy in and now sell out ?).

Only time will tell, but until the BOD shows a modicum of competence and professionalism, I will continue to be skeptical about their performance and motives. (I still have faith in our main product, but not in the management controlling it).

The only other investments I know of that Jim has been involved in have turned to doo doo and or gone down the drain. Lets see where Juvenescence is in a couple of years from now. Maybe RPG issue a S H I T load of shares and take them over too..... LOL

I see there is now the usual sell off which I am sure will not abate until the SP is back down to the purchase price of 0.065..... Hopefully an announcement regarding a US license will be made before that happens as we have no money and are running on fumes, although if not, another placing is just around the corner even if just to cover the ATO.

And to be clear. The dilution effects to existing shareholders is 23%
(not 18% which is the % of the total combined share cap). They deliberately calculate it this way to make it look less.

A discount of approximately 43.09 per cent to the closing price of HK$0.123 per Share
as quoted on the HK Stock Exchange on 2 September 2020, being the date of the
Share Purchase Agreements;

If they are going to quote this ****e and rub it in shareholders faces, they should have issued the shares at this price, shouldnt they..... The only ones who gain are those involved in DLI.
We have been played and shafted once again.

Total dilution for these and Jamie's shares from last year (when they come into play just before the recently announced FDA approval) = 37.44%

Make your own minds up about whether its all been part of the bigger game plan with the unbelievable FDA delays. Talk about moving money from one hand to the hands of mates. It certainly feels that way....or am I unjustly being paranoid ? :-O

Its once again a case of "mates rates". Look at who is already involved in the company.
James Mellon is a non-executive director (one of four directors sitting on the board)
and direct shareholder of InSilico Medicine Cayman TopCo, holding, together with Galloway
Limited (“Galloway”), which is a private limited liability company indirectly wholly-owned by James Mellon, in aggregate approximately 1.66 per cent. of its issued share capital. Juvenescence Limited, in which Mr Mellon is the chairman and a shareholder holding, together with Galloway, approximately 18.59 per cent. of its issued share capital, directly holds approximately 11.63 per cent. of InSilico Medicine Cayman TopCo’s issued share capital. InSilico Medicine Cayman TopCo is the parent company of Insilico Medicine IP Limited and InSilico Medicine Cayman SubCo, both of which are shareholders of DLI, holding approximately 13.18 per cent. and approximately 11.53 per cent., respectively, of DLI’s issued share capital and Insilico Medicine IP Limited is the Sellers’ Warrantor in respect of the operational warranties given under the Majority Share Purchase Agreement. On closing of the Acquisition, James Mellon will step down as a nonexecutive director of InSilico Medicine Cayman TopCo.

So what happened to the CBD market ???

Medicine with financing from prominent investors worldwide. What prominent investors ???

Surely if it was that good, why sell to incompetence for only 3.7 mill usd

My last post tonight ... lol

So... no income, a tax bill to pay and another company to support. They must be confident of receiving something soon, otherwise what ? They cannot surely be thinking of a cash call after issuing 422+ mill shares for the T/O ?

Oh.... that’s what they do
DLI is developing explainable and user-friendly artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological and psychological levels. It is also developing systems for the emerging field of longevity medicine enabling physicians to make better decisions on the interventions that may slow down or reverse the aging processes. DLI developed Longevity as a Service (LaaS)© solution to integrate multiple deep biomarkers of aging dubbed “deep aging clocks” to provide a universal multifactorial measure of human biological age.

The acquisition will allow the Group to expand into the global wellness market that was estimated to be over US$4.20 trillion in 2017. Further, there is an increased interest in the longevity market where DLI is looking to have first mover advantage with its applications including COVID-19 relevance

I’ll believe it when I see it. With our current management, there is no way. Regent needs new blood. I wonder if the DLI management are yes men too ?

At least we get to vote on it.......although it won’t make any difference what existing non company shareholders think...

Looks like it excludes JG,s shares.

So how is this going to add value to the company ? What do they do ? What do they have ? I assume JM already has some interest and probably coerced our BOD (just like the DBC) to invest. Hopefully I’ll be proved wrong and something does come of this one and JM doesn’t eventually buy it from Regent for 200k+ squid n 3 years.

Sorry, but historical incompetence makes one ask such questions and speculate on the future outcome.

422.69 million Consideration Shares, representing a dilution of approximately 18.70 per cent of the issued share capital of the Company........

If that’s issued share cap, can we assume it doesn’t include the additional shares owned by JG ???.. Anyone ?

So DLI are up by 83%.

So we have our answer. The sp has been driven up because of this. And I wouldn’t be surprised if those in DLI who have been buying pre announcement will be selling during the next few days. Seems the logical answer. I wouldn’t be surprised to see a sell off now (hopefully I’m wrong, but the price action/announcement timing all stinks to me. Looks like we’ve been played yet again)

Well.....there you have it....At least it’s not too much at 3.79mill usd, but then again it was for 0.067hkd a share.... Who the hell are DLI (just another DBS ?).
The Board is pleased to announce that today (after market close) the Company entered into legally binding Share Purchase Agreements with all the shareholders and DLI ESOP award recipients of DLI in respect of the conditional Acquisition of the issued and outstanding shares and DLI ESOP awards in DLI by the Company for approximately US$3.79 million (or approximately HK$29.56 million), to be satisfied by way of the issuance of Consideration Shares, the number of which was determined pursuant to an exchange ratio based on the valuation attributed to DLI and a Share price of HK$0.070 per Share, which was referable to: (i) the closing Share price of HK$0.067 per Share on 29 May 2020

The same as last week and the week before that and the week before that. Since the first operations update on the 18th June (there have been 2). But what part is anyone's guess since none of the updates make much sense apart from further delays and smoke n mirrors (most here, myself included, are just making speculations and we know where speculating has gotten us before). The only people who really know are the ones that have leaked the information...whatever that may be.

Ahhh but how many shares did the company have back then ?

If only 10 :-), then market cap would have been 170$, so share price is only relevant if we know the quantity... So much easier to understand and feel if market cap is quoted. ;-)